Use Case : Virtual reality without dizziness: when Emoticonnect deciphers the emotional impact of the Stimbox® by Neural Balance Innovation

Virtual reality fascinates as much as it disorients. While it promises total immersion, it often comes with a well-known side effect: “motion sickness,” or virtual travel sickness. This discomfort is experienced by nearly 60% of users, causing dizziness, unease, or anticipatory anxiety.

But a French innovation is changing the game. Neural Balance Innovation (NBI) has developed the Stimbox®, a galvanic vestibular stimulation (GVS) device capable of realigning the senses and restoring the connection between the body and visual perception. And for the first time, Emoticonnect has analyzed its emotional impact at scale.

When technology reconciles the body and emotion

Through the analysis of more than 175,000 semantic data points collected from across the web, Emoticonnect has mapped the feelings associated with virtual reality. The results are telling:

Traditional VR: 58% negative emotions, dominated by disorientation and frustration.

With the Stimbox®, this dynamic shifts. The experience becomes smooth, calming, almost natural. The body is no longer in resistance—it becomes an ally to immersion.

“The Stimbox® doesn’t aim to intensify the virtual, but to restore balance,” explains Neural Balance Innovation.

This approach marks a profound shift: virtual reality is no longer trying to impress, but to make people feel good.

From therapeutic VR to wellness-focused VR

The emotional data collected reveals a major shift: VR is moving from a performance-driven universe toward a logic of sensory well-being. Four trends are emerging:

Therapeutic VR: a new tool to help treat phobias, anxiety, and pain.

Professional VR: prolonged immersion that fosters focus and a sense of pride in use.

Consumer VR: renewed enjoyment, accessible to all, without discomfort.

Sovereign VR: a French innovation that is ethical and respectful of the human body.

In other words, virtual reality is entering the era of digital serenity.

What if motion sickness became an emotional opportunity?

The Emoticonnect study broadens the perspective: motion sickness—whether real or virtual—triggers a true sensory coherence crisis, combining fear, frustration, and loss of reference points. But it is also a space for emotional learning—an environment where the body can relearn how to stabilize itself.

Thanks to innovations like the Stimbox®, researchers are beginning to envision assisted emotional regulation—a future where mobility, whether physical or virtual, becomes a controlled experience.

“The body and technology must learn to interact again,” emphasizes Emoticonnect, advocating for an ethics of emotion at the heart of innovation.

A technology of calm

Designed and manufactured in France, the Stimbox® positions itself as a technology of calm: a gentle, precise, and sovereign innovation, where performance is no longer measured in speed or power, but in perceived serenity.

What this collaboration reveals

The joint Emoticonnect x NBI study highlights a fundamental transformation in our relationship with technology: the shift from performance-driven innovation to emotionally sustainable innovation.

It shows that emotional comfort is no longer optional, but a key criterion for technological success. And that by reconciling the senses and emotions, France can position itself as a pioneer of more human-centered technology.

About Emoticonnect

Emoticonnect is the European leader in emotional and predictive data. In partnership with the CNRS, its semantic analysis technology measures, anticipates, and maps human emotions to understand behaviors and guide innovation strategies.

About Neural Balance Innovation (NBI)

Neural Balance Innovation develops vestibular stimulation and sensory regulation solutions. Its patented Stimbox® technology introduces a new generation of human-machine interfaces aligned with the human body.